Clin2
NCT05283382Possibly a fitRecruiting

Cannabidiol trial for learning and anxiety

Anxiety and Fear

Part of Mental health clinical trials.

This early-phase study tests how cannabidiol (CBD) affects learning and anxiety. You may be able to join if you meet age and health requirements and have not used CBD or other cannabis recently.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
160 people
Ages
18 years to 50 years
Study type
Interventional

Who can take part

  • You are between 18 and 50 years old.
  • You have not taken CBD in the last 24 hours.
  • You have not used any cannabis product (like marijuana or THC products) in the last 24 hours.
  • You do not have heart problems or heart disease.
  • You do not have certain brain or nervous system conditions (like epilepsy, stroke, multiple sclerosis, brain tumor, blood-vessel problems, or aneurysm).
  • You are not pregnant and not breast-feeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05649059Recruiting· Phase 4
Cannabidiol study for social anxiety symptoms

This trial studies whether cannabidiol (CBD) helps improve social anxiety symptoms. You may be able to join if you are an adult with significant social anxiety and meet medication and health safety requirements.

Cambridge, Massachusetts
NCT05457465Recruiting· Phase 2
Cannabidiol study for anxiety and depression in bipolar disorder

This Phase 2 study tests whether cannabidiol (CBD) can reduce anxiety and depressive symptoms in people with bipolar disorder. It may help if your mood symptoms are persistent and you’re already on stable bipolar medications.

Belmont, Massachusetts
NCT07278505Recruiting· Phase 1/Phase 2
CBD and brain imaging study for young adults with stress

This trial tests whether cannabidiol (CBD), a compound from cannabis, can help reduce stress in young adults who have experienced early-life adversity. You will have brain scans and take CBD or a placebo to see how it affects your stress and anxiety.

New York, New York
NCT07123467Recruiting· Phase 3
Study on CBD and learning for generalized anxiety

This trial tests if adding cannabidiol (CBD) to a learning-based approach helps manage generalized anxiety disorder (GAD). It involves brain scans and taking CBD daily.

Detroit, Michigan
NCT05320367Not yet recruiting· Phase 1/Phase 2
Breathing in cannabidiol to test safety in occasional cannabis users

This Phase 1/2 study tests whether inhaled cannabidiol (CBD) is safe and well-tolerated in healthy people who use cannabis occasionally. You’d be asked to avoid other cannabis and certain drugs around study visits so researchers can measure your response clearly.

NCT05885542Recruiting· Phase 1/Phase 2
Testing CBD pills for cannabis use and stress in young adults

This early-phase study tests whether a CBD pill (compared with a placebo sugar pill) can affect cannabis use and stress in people ages 18–25 who use cannabis very frequently. It may help your stress levels and cannabis-related symptoms while researchers carefully monitor safety and abstinence periods during visits.

Charleston, South Carolina

Hear when a new Anxiety and Fear trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.